Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

331.23 -3.41 (-1.02%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Stryker Corp

< Previous 1 2 3 Next >
Stryker Completes Acquisition of Artelon, Inc.
From Stryker
Via Business Wire
Stryker to announce financial results for its second quarter of fiscal year 2024
From Stryker Corporation
Via GlobeNewswire
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
From Stryker
Via Business Wire
Stryker Corp. (NYSE: SYK) Sets New 52-Week High in Thursday Session
Via Investor Brand Network
Stryker declares a $0.80 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker reports first quarter 2024 operating results
From Stryker Corporation
Via GlobeNewswire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
Stryker to announce financial results for its first quarter of fiscal year 2024
From Stryker Corporation
Via GlobeNewswire
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
Stryker declares a $0.80 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day
From Stryker Corporation
Via GlobeNewswire
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
From Stryker
Via Business Wire
4 med tech stocks with improving prognosis for 2024
MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025. 
Via MarketBeat
Exposures COVID-19
Stryker reports 2023 operating results and 2024 outlook
From Stryker Corporation
Via GlobeNewswire
New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients
From Stryker
Via Business Wire
First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
From Stryker
Via Business Wire
Stryker announces 2023 sales surpassed $20 billion
From Stryker Corporation
Via GlobeNewswire
Stryker to announce financial results for its fourth quarter and full year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker announces intention to nominate a new director, Rachel Ruggeri
From Stryker Corporation
Via GlobeNewswire
Stryker announces Dr. Srikant Datar will retire from Board of Directors
From Stryker Corporation
Via GlobeNewswire
Stryker declares a $0.80 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Medtronic: oversold, overextended high yield reversal in play
The reversal in Medtronic has been brewing for some time but is gaining traction after strong second quarter earnings that came with improved guidance 
Via MarketBeat
Exposures COVID-19
Stryker reports third quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
From Stryker Corporation
Via GlobeNewswire
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year
From Stryker
Via Business Wire
Stryker to host investor day
From Stryker Corporation
Via GlobeNewswire
Stryker to announce financial results for its third quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
From Stryker
Via Business Wire
Stryker’s Pangea Systems Receive FDA Clearance
From Stryker
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.